Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gilotrif Compassionate Use in Advanced NSCLC
NCT02747953Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of afatinib in non-small cell lung cancer (NSCLC), sponsored by Samsung Medical Center. Started Jul 2011; status: completed.
02
Drugs
afatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02747953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02747953.